SCHEMBL30890665

SCHEMBL30890665

O=C1NC2(CCCC2)C[C@@]12CCNC2

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.46
POLB P06746 1/20 0.30
ALDH1A1 P00352 1/20 0.30
BACE1 P56817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8420648 0.87 CRBN (0.35) CRBNPOLBALDH1A1
SCHEMBL30541894 0.79 CRBN (0.55) CRBNBACE1
SCHEMBL21238839 0.69 CRBN (0.53) CRBNBACE1
SCHEMBL21238837 0.68 CRBN (0.52) CRBNBACE1
Hydrochloric Acid SCHEMBL31730231 0.68 CRBN (0.52) CRBNBACE1
SCHEMBL23199583 0.67 CRBN (0.61) CRBNBACE1
SCHEMBL21238835 0.67
SCHEMBL12501024 0.67 CRBN (0.61) CRBNBACE1
SCHEMBL12500998 0.67 CRBN (0.55) CRBNBACE1
SCHEMBL29749879 0.67 CRBN (0.50) CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 WO disclosed